Frontlight ResearchEarly access
WithdrawnNo phase
Community Outreach-based Study to Increase Cervical Cancer Screening Among Hispanic Women in Cleveland
Key facts
- Who runs it
- MetroHealth Medical Center
- Where
- Cleveland, United StatesSee the site
- Trial code
- Status
- Withdrawn
- Started
- 1 Feb 2023
- Ended
- 27 Nov 2024
- Type of study
- Observational
- Record updated
- 7 March 2025
- Why it stopped
- Personnel departure.
Who can take part
- Age
- 30 years to 65 years
- Sex
- Women only
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- Hispanic women aged 30 and 65 years
- Residing in the City of Cleveland
Who cannot take part
- Women who are pregnant
- Had a hysterectomy
- Women who had pap test in the past three years or hrHPV test in the past five years or co-testing (hrHPV + pap test) in the past five years
Where in United States
- MetroHealth Medical CenterCleveland, United States
About the trial
What the trial wants to find out
This study offers Hispanic women who are eligible for cervical cancer screening residing in the Cleveland metropolitan area one of two possible community outreach-based cervical cancer screening modalities, self-collection home HPV test or clinic-based pap test, which is the current standard of care, to assess if these strategies improve cervical cancer screening rates in this population group.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Using a Community-based Participatory Approach to Reduce Disparities in Cervical Cancer Prevention, Screening, and Diagnosis Among Hispanic Women in Cleveland
- Record updated
- 7 March 2025